Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vladimir Zah, Rowe B Brookfield, Martina Imro, Simona Tatovic, Jovana Pelivanovic & Djurdja Vukicevic. (2019) Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016. Journal of Pain Research 12, pages 3037-3048.
Read now
Read now
Flaminia Coluzzi & Matteo Ruggeri. (2014) Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Current Medical Research and Opinion 30:6, pages 1139-1151.
Read now
Read now
Nancy Neil, Sanjay Merchant, David Provenzano, Kristine Ogden & Samir H. Mody. (2013) Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States. Journal of Medical Economics 16:2, pages 307-317.
Read now
Read now
Articles from other publishers (19)
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Costanza Santori, Francesco Rosiello & Flaminia Coluzzi. (2021) Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain. Clinical Drug Investigation 41:10, pages 875-883.
Crossref
Crossref
Lucien Roulet, Victoria Rollason, Jules Desmeules & Valérie Piguet. (2021) Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients. Drugs 81:11, pages 1257-1272.
Crossref
Crossref
Sheeja Manchira Krishnan, Vijay Singh Gc, Harbinder Kaur Sandhu, Martin Underwood, Sam Eldabe, Andrea Manca & Cynthia P Iglesias Urrutia. (2020) Protocol for an economic analysis of the randomised controlled trial of Improving the Well-being of people with Opioid Treated CHronic pain: I-WOTCH Study. BMJ Open 10:11, pages e037243.
Crossref
Crossref
Junxiang Zhou, Yixin Wang & Gang Jiang. (2020) Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation. PLOS ONE 15:4, pages e0231763.
Crossref
Crossref
Anna Heath, Natalia Kunst, Christopher Jackson, Mark Strong, Fernando Alarid-Escudero, Jeremy D. Goldhaber-Fiebert, Gianluca Baio, Nicolas A. Menzies & Hawre Jalal. (2020) Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Medical Decision Making 40:3, pages 314-326.
Crossref
Crossref
Insa Backhaus, Alice Mannocci & Giuseppe La Torre. (2019) A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment. Current Pharmaceutical Biotechnology 20:11, pages 910-919.
Crossref
Crossref
Christopher Ll. Morgan, Sara Jenkins-Jones, Craig Currie & Garth Baxter. (2019) Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study. Advances in Therapy 36:6, pages 1412-1425.
Crossref
Crossref
Anna Heath, Ioanna Manolopoulou & Gianluca Baio. (2019) Estimating the Expected Value of Sample Information across Different Sample Sizes Using Moment Matching and Nonlinear Regression. Medical Decision Making 39:4, pages 347-359.
Crossref
Crossref
Sheena Derry, Andrew SC Rice, Peter Cole, Toni Tan & R Andrew Moore. (2017) Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Crossref
W. Sullivan, M. Hirst, S. Beard, D. Gladwell, F. Fagnani, J. López Bastida, C. Phillips & W. C. N. Dunlop. (2015) Economic evaluation in chronic pain: a systematic review and de novo flexible economic model. The European Journal of Health Economics 17:6, pages 755-770.
Crossref
Crossref
Escarlata López Ramírez, D. M. Muñoz Carmona, J. Contreras Martínez & A. de la Torre Luque. (2016) Tapentadol in the management of opioid-naïve patients with cancer pain. Revista de la Sociedad Española del Dolor 23.
Crossref
Crossref
Olfat Zekry & Charles A. Inderjeeth. (2015) Comment on “Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?”. Drugs & Aging 32:10, pages 871-873.
Crossref
Crossref
Lourdes Ferreira Laso, Amanda López Picado, Fernando Antoñanzas Villar, Laura Lamata de la Orden, Mar Ceballos Garcia, Carolina Ibañez López, Lorena Pipaon Ruilope, Felix Lamata Hernandez, Cesar Valero Martinez, Felipe Aizpuru & Roberto Hernandez Chaves. (2015) Cost-Effectiveness Analysis of Levobupivacaine 0.5 %, a Local Anesthetic, Infusion in the Surgical Wound After Modified Radical Mastectomy. Clinical Drug Investigation 35:9, pages 575-582.
Crossref
Crossref
Felicity C. Veal & Gregory M. Peterson. (2015) Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?. Drugs & Aging 32:6, pages 419-426.
Crossref
Crossref
Robert Andrew Moore, Sheena Derry, Lee S. Simon & Paul Emery. (2013) Nonsteroidal Anti‐Inflammatory Drugs, Gastroprotection, and Benefit–Risk. Pain Practice 14:4, pages 378-395.
Crossref
Crossref
R. Andrew, Sheena Derry, Rod S. Taylor, Sebastian Straube & Ceri J. Phillips. (2014) The Costs and Consequences of Adequately Managed Chronic Non-Cancer Pain and Chronic Neuropathic Pain. Pain Practice 14:1, pages 79-94.
Crossref
Crossref
R. Andrew Moore. (2013) What works for whom? Determining the efficacy and harm of treatments for pain. Pain 154:Supplement 1, pages S77-S86.
Crossref
Crossref
R. A. Moore, S. Straube & D. Aldington. (2013) Pain measures and cut-offs - ‘no worse than mild pain’ as a simple, universal outcome. Anaesthesia 68:4, pages 400-412.
Crossref
Crossref
Sheena Derry, Andrew S C Rice, Peter Cole, Toni Tan & R Andrew Moore. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.